Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Mesoblast (MESO) EBIT Margin: 2014-2023

Historic EBIT Margin for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -2,030.25%.

  • Mesoblast's EBIT Margin rose 71975.00% to -2,030.25% in Q2 2023 from the same period last year, while for Jun 2023 it was -124.45%, marking a year-over-year increase of 9294.00%. This contributed to the annual value of -360.79% for FY2025, which is 74287.00% up from last year.
  • As of Q2 2023, Mesoblast's EBIT Margin stood at -2,030.25%, which was down 445.90% from 586.95% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's EBIT Margin ranged from a high of 1,537.31% in Q1 2019 and a low of -4,929.45% during Q2 2021.
  • For the 3-year period, Mesoblast's EBIT Margin averaged around -581.23%, with its median value being 514.16% (2022).
  • Per our database at Business Quant, Mesoblast's EBIT Margin slumped by 510,679bps in 2020 and then skyrocketed by 524,810bps in 2021.
  • Over the past 5 years, Mesoblast's EBIT Margin (Quarterly) stood at 813.83% in 2019, then slumped by 6,563bps to 748.19% in 2020, then slumped by 16,024bps to 587.96% in 2021, then crashed by 9,761bps to 490.35% in 2022, then spiked by 71,975bps to -2,030.25% in 2023.
  • Its EBIT Margin stands at -2,030.25% for Q2 2023, versus 586.95% for Q1 2023 and 490.35% for Q4 2022.